List of Excipients in API neomycin sulfate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing neomycin sulfate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Alcon Laboratories Inc | MAXITROL | neomycin sulfate, polymyxin b sulfate and dexamethasone | 0065-0631 | LANOLIN | |
| Alcon Laboratories Inc | MAXITROL | neomycin sulfate, polymyxin b sulfate and dexamethasone | 0065-0631 | METHYLPARABEN | |
| Alcon Laboratories Inc | MAXITROL | neomycin sulfate, polymyxin b sulfate and dexamethasone | 0065-0631 | PETROLATUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing neomycin sulfate
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 | CALCIUM STEARATE |
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 | POVIDONE K30 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 | ALCOHOL |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for neomycin sulfate
Excipient focus: ACETIC ACID
neomycin sulfate drug variants containing ACETIC ACID
neomycin sulfate drug variants not containing ACETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
neomycin sulfate drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| Rebel Distributors Corp | neomycin sulfate, polymyxin b sulfate and gramicidin | 21695-528 |
| Bausch & Lomb Incorporated | neomycin sulfate, polymyxin b sulfate and gramicidin | 24208-790 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| Hi-Tech Pharmacal Co Inc | neomycin sulfate | 50383-565 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
neomycin sulfate drug variants containing AMMONIA
neomycin sulfate drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
neomycin sulfate drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| Chartwell RX LLC | neomycin sulfate | 62135-443 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| Hi-Tech Pharmacal Co Inc | neomycin sulfate | 50383-565 |
| >Company | >Ingredient | >NDC |
Excipient focus: BENZALKONIUM CHLORIDE
neomycin sulfate drug variants containing BENZALKONIUM CHLORIDE
neomycin sulfate drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
neomycin sulfate drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Medimetriks Pharmaceuticals | neomycin sulfate and fluocinolone acetonide | 43538-940 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM STEARATE
neomycin sulfate drug variants containing CALCIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing CALCIUM STEARATE
Excipient focus: CETYL ALCOHOL
neomycin sulfate drug variants containing CETYL ALCOHOL
neomycin sulfate drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
neomycin sulfate drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Medimetriks Pharmaceuticals | neomycin sulfate and fluocinolone acetonide | 43538-940 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: CUPRIC SULFATE
neomycin sulfate drug variants containing CUPRIC SULFATE
neomycin sulfate drug variants not containing CUPRIC SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
neomycin sulfate drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Medimetriks Pharmaceuticals | neomycin sulfate and fluocinolone acetonide | 43538-940 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
neomycin sulfate drug variants containing GLYCERIN
neomycin sulfate drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
neomycin sulfate drug variants containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | neomycin sulfate, polymyxin b sulfate and hydrocortisone | 16590-347 |
| Sandoz Inc | neomycin sulfate, polymyxin b sulfate and hydrocortisone | 61314-641 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
neomycin sulfate drug variants containing HYDROCHLORIC ACID
neomycin sulfate drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
neomycin sulfate drug variants containing HYPROMELLOSE
neomycin sulfate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
neomycin sulfate drug variants containing HYPROMELLOSE 2910
neomycin sulfate drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
neomycin sulfate drug variants containing HYPROMELLOSES
neomycin sulfate drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: LANOLIN
neomycin sulfate drug variants containing LANOLIN
neomycin sulfate drug variants not containing LANOLIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: LIGHT MINERAL OIL
neomycin sulfate drug variants containing LIGHT MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | neomycin sulfate, polymyxin b sulfate and hydrocortisone acetate | 54868-1531 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing LIGHT MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
neomycin sulfate drug variants containing METHYLPARABEN
neomycin sulfate drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: MINERAL OIL
neomycin sulfate drug variants containing MINERAL OIL
neomycin sulfate drug variants not containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: PEG-20 SORBITAN OLEATE
neomycin sulfate drug variants containing PEG-20 SORBITAN OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | neomycin sulfate, polymyxin b sulfate and hydrocortisone | 50090-2365 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing PEG-20 SORBITAN OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: PETROLATUM
neomycin sulfate drug variants containing PETROLATUM
neomycin sulfate drug variants not containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
neomycin sulfate drug variants containing POLOXAMER 188
neomycin sulfate drug variants not containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
neomycin sulfate drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | neomycin sulfate, polymyxin b sulfate and gramicidin | 21695-528 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 20 CETOSTEARYL ETHER
neomycin sulfate drug variants containing POLYOXYL 20 CETOSTEARYL ETHER
| Company | Ingredient | NDC |
|---|---|---|
| Medimetriks Pharmaceuticals | neomycin sulfate and fluocinolone acetonide | 43538-940 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing POLYOXYL 20 CETOSTEARYL ETHER
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 40 STEARATE
neomycin sulfate drug variants containing POLYOXYL 40 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | neomycin sulfate, polymyxin b sulfate and hydrocortisone | 16590-347 |
| Sandoz Inc | neomycin sulfate, polymyxin b sulfate and hydrocortisone | 61314-641 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing POLYOXYL 40 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 20
neomycin sulfate drug variants containing POLYSORBATE 20
neomycin sulfate drug variants not containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
neomycin sulfate drug variants containing POLYSORBATE 80
neomycin sulfate drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM METABISULFITE
neomycin sulfate drug variants containing POTASSIUM METABISULFITE
neomycin sulfate drug variants not containing POTASSIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
neomycin sulfate drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| Hi-Tech Pharmacal Co Inc | neomycin sulfate | 50383-565 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Chartwell RX LLC | neomycin sulfate | 62135-443 |
| Bryant Ranch Prepack | neomycin sulfate | 63629-8352 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
neomycin sulfate drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Chartwell RX LLC | neomycin sulfate | 62135-443 |
| Bryant Ranch Prepack | neomycin sulfate | 63629-8352 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| Hi-Tech Pharmacal Co Inc | neomycin sulfate | 50383-565 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
neomycin sulfate drug variants containing PROPYLENE GLYCOL
neomycin sulfate drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
neomycin sulfate drug variants containing PROPYLPARABEN
neomycin sulfate drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
neomycin sulfate drug variants containing SODIUM CHLORIDE
neomycin sulfate drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
neomycin sulfate drug variants containing SODIUM HYDROXIDE
neomycin sulfate drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
neomycin sulfate drug variants containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Medimetriks Pharmaceuticals | neomycin sulfate and fluocinolone acetonide | 43538-940 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: SULFURIC ACID
neomycin sulfate drug variants containing SULFURIC ACID
neomycin sulfate drug variants not containing SULFURIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: THIMEROSAL
neomycin sulfate drug variants containing THIMEROSAL
neomycin sulfate drug variants not containing THIMEROSAL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
neomycin sulfate drug variants containing WATER
neomycin sulfate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: WHITE WAX
neomycin sulfate drug variants containing WHITE WAX
| Company | Ingredient | NDC |
|---|---|---|
| Medimetriks Pharmaceuticals | neomycin sulfate and fluocinolone acetonide | 43538-940 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing WHITE WAX
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Excipient focus: ZINC CHLORIDE
neomycin sulfate drug variants containing ZINC CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | neomycin sulfate and polymyxin b sulfate, bacitracin zinc and hydrocortisone acetate | 21695-736 |
| >Company | >Ingredient | >NDC |
neomycin sulfate drug variants not containing ZINC CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | neomycin sulfate | 0093-1177 |
| Lannett Company Inc | neomycin sulfate | 0527-1210 |
| XGen Pharmaceuticals DJB Inc | neomycin sulfate | 39822-0310 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
